Biophysical studies reveal modulation of ion channels in Alzheimer's disease, indicating potential therapeutic avenues.
Kinase-mediated regulation of ion channels is central to numerous cellular signaling pathways, yet the molecular underpinnings of these protein-protein interactions (PPIs) remain incompletely defined. Here, we present ongoing biophysical studies aimed at elucidating the interaction mechanisms between a key kinase, glycogen synthase kinase 3 β (GSK3β), and its target ion channel, voltage-gated sodium channel 1.6 (Nav1.6). Dysregulation of Nav1.6 and overexpression of GSK3β have been directly linked to network hyperexcitability, a hallmark of early-stage Alzheimer's disease and other neuropsychiatric disorders. Utilizing a combination of biochemical and functional assays—including surface plasmon resonance (SPR), split-luciferase complementation assay (LCA), chemoinformatics, kinase assays, and electrophysiology—we are characterizing the affinity, dynamics, and conformational consequences of their association. Furthermore, we leverage a proprietary library of small molecule MZ compounds, derived from the known 1063 compound, to probe and modulate the GSK3β/Nav1.6 PPI. Our preliminary findings offer new insights into the regulatory principles governing these complexes, revealing dynamic adaptability that may be relevant to signaling networks. This work provides a platform for understanding the structural determinants of kinase-ion channel modulation and sets the stage for future functional and therapeutic explorations aimed at neurodegenerative and neuropsychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Gurtu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: